Innovstone Therapeutics Limited
Clinical trials sponsored by Innovstone Therapeutics Limited, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New inhaled drug SYH2059 begins first human safety tests Results expected Dec 2026 (estimated)
- Could a new pill quiet the mind? early trial puts SYH2056 to the test Results expected Jan 2027 (estimated)
- New experimental drug SYH2072 tested in humans for the first time Results expected Feb 2027 (estimated)